Impel NeuroPharma Completes Industry's First Nose-to-Brain Human Imaging Study
4/18/2013 11:32:18 AM
More...
|
Impel NeuroPharma Announces Commercial Milestones and First-in-Human Use of Pressurized Olfactory Delivery (POD) Technology
6/14/2012 10:37:00 AM
More...
|
Impel NeuroPharma Awarded Phase II SBIR by Department of Defense for Blood-Brain Barrier Bypass Technology
6/24/2011 9:07:24 AM
More...
|